Potential of Tryptamine Derivatives as Multi-Target Directed Ligands for Alzheimer’s Disease: AChE, MAO-B, and COX-2 as Molecular Targets. This evidence concerns the gene PTGS2 and early-onset autosomal dominant Alzheimer disease.